Abstract

The tumor microenvironment is replete with cells that evolve with and provide support to tumor cells during the transition to malignancy. The hijacking of the immune system in the pancreatic tumor microenvironment is suggested to contribute to the failure to date to produce significant improvements in pancreatic cancer survival by various chemotherapeutics. Regulatory T cells, myeloid derived suppressor cells, and fibroblasts, all of which constitute a complex ecology microenvironment, can suppress CD8+ T cells and NK cells, thus inhibiting effector immune responses. Tumor-associated macrophages (TAM) are versatile immune cells that can express different functional programs in response to stimuli in tumor microenvironment at different stages of pancreatic cancer development. TAM have been implicated in suppression of anti-tumorigenic immune responses, promotion of cancer cell proliferation, stimulation of tumor angiogenesis and extracellular matrix breakdown, and subsequent enhancement of tumor invasion and metastasis. Many emerging agents that have demonstrated efficacy in combating other types of tumors via modulation of macrophages in tumor microenvironments are, however, only marginally studied for pancreatic cancer prevention and treatment. A better understanding of the paradoxical roles of TAM in pancreatic cancer may pave the way to novel preventive and therapeutic approaches. Here we give an overview of the recruitment and differentiation of macrophages, TAM and pancreatic cancer progression and prognosis, as well as the potential preventive and therapeutic targets that interact with TAM for pancreatic cancer prevention and treatment.

Original languageEnglish (US)
Pages (from-to)50735-50754
Number of pages20
JournalOncotarget
Volume7
Issue number31
DOIs
StatePublished - Jan 1 2016

Fingerprint

Pancreatic Neoplasms
Macrophages
Tumor Microenvironment
Neoplasms
Regulatory T-Lymphocytes
Ecology
Natural Killer Cells
Extracellular Matrix
Immune System
Fibroblasts
Cell Proliferation
Neoplasm Metastasis
T-Lymphocytes

All Science Journal Classification (ASJC) codes

  • Oncology

Keywords

  • Chemoprevention
  • Pancreatic cancer
  • Tumor microenvironment
  • Tumor-associated macrophages

Cite this

@article{79b3024a0f4f4a4fa3e34362a4776917,
title = "Targeting tumor-associated macrophages to combat pancreatic cancer",
abstract = "The tumor microenvironment is replete with cells that evolve with and provide support to tumor cells during the transition to malignancy. The hijacking of the immune system in the pancreatic tumor microenvironment is suggested to contribute to the failure to date to produce significant improvements in pancreatic cancer survival by various chemotherapeutics. Regulatory T cells, myeloid derived suppressor cells, and fibroblasts, all of which constitute a complex ecology microenvironment, can suppress CD8+ T cells and NK cells, thus inhibiting effector immune responses. Tumor-associated macrophages (TAM) are versatile immune cells that can express different functional programs in response to stimuli in tumor microenvironment at different stages of pancreatic cancer development. TAM have been implicated in suppression of anti-tumorigenic immune responses, promotion of cancer cell proliferation, stimulation of tumor angiogenesis and extracellular matrix breakdown, and subsequent enhancement of tumor invasion and metastasis. Many emerging agents that have demonstrated efficacy in combating other types of tumors via modulation of macrophages in tumor microenvironments are, however, only marginally studied for pancreatic cancer prevention and treatment. A better understanding of the paradoxical roles of TAM in pancreatic cancer may pave the way to novel preventive and therapeutic approaches. Here we give an overview of the recruitment and differentiation of macrophages, TAM and pancreatic cancer progression and prognosis, as well as the potential preventive and therapeutic targets that interact with TAM for pancreatic cancer prevention and treatment.",
keywords = "Chemoprevention, Pancreatic cancer, Tumor microenvironment, Tumor-associated macrophages",
author = "Ran Cui and Wen Yue and Edmund Lattime and Mark Stein and Qing Xu and Xianglin Tan",
year = "2016",
month = "1",
day = "1",
doi = "10.18632/oncotarget.9383",
language = "English (US)",
volume = "7",
pages = "50735--50754",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "31",

}

Targeting tumor-associated macrophages to combat pancreatic cancer. / Cui, Ran; Yue, Wen; Lattime, Edmund; Stein, Mark; Xu, Qing; Tan, Xianglin.

In: Oncotarget, Vol. 7, No. 31, 01.01.2016, p. 50735-50754.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Targeting tumor-associated macrophages to combat pancreatic cancer

AU - Cui, Ran

AU - Yue, Wen

AU - Lattime, Edmund

AU - Stein, Mark

AU - Xu, Qing

AU - Tan, Xianglin

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The tumor microenvironment is replete with cells that evolve with and provide support to tumor cells during the transition to malignancy. The hijacking of the immune system in the pancreatic tumor microenvironment is suggested to contribute to the failure to date to produce significant improvements in pancreatic cancer survival by various chemotherapeutics. Regulatory T cells, myeloid derived suppressor cells, and fibroblasts, all of which constitute a complex ecology microenvironment, can suppress CD8+ T cells and NK cells, thus inhibiting effector immune responses. Tumor-associated macrophages (TAM) are versatile immune cells that can express different functional programs in response to stimuli in tumor microenvironment at different stages of pancreatic cancer development. TAM have been implicated in suppression of anti-tumorigenic immune responses, promotion of cancer cell proliferation, stimulation of tumor angiogenesis and extracellular matrix breakdown, and subsequent enhancement of tumor invasion and metastasis. Many emerging agents that have demonstrated efficacy in combating other types of tumors via modulation of macrophages in tumor microenvironments are, however, only marginally studied for pancreatic cancer prevention and treatment. A better understanding of the paradoxical roles of TAM in pancreatic cancer may pave the way to novel preventive and therapeutic approaches. Here we give an overview of the recruitment and differentiation of macrophages, TAM and pancreatic cancer progression and prognosis, as well as the potential preventive and therapeutic targets that interact with TAM for pancreatic cancer prevention and treatment.

AB - The tumor microenvironment is replete with cells that evolve with and provide support to tumor cells during the transition to malignancy. The hijacking of the immune system in the pancreatic tumor microenvironment is suggested to contribute to the failure to date to produce significant improvements in pancreatic cancer survival by various chemotherapeutics. Regulatory T cells, myeloid derived suppressor cells, and fibroblasts, all of which constitute a complex ecology microenvironment, can suppress CD8+ T cells and NK cells, thus inhibiting effector immune responses. Tumor-associated macrophages (TAM) are versatile immune cells that can express different functional programs in response to stimuli in tumor microenvironment at different stages of pancreatic cancer development. TAM have been implicated in suppression of anti-tumorigenic immune responses, promotion of cancer cell proliferation, stimulation of tumor angiogenesis and extracellular matrix breakdown, and subsequent enhancement of tumor invasion and metastasis. Many emerging agents that have demonstrated efficacy in combating other types of tumors via modulation of macrophages in tumor microenvironments are, however, only marginally studied for pancreatic cancer prevention and treatment. A better understanding of the paradoxical roles of TAM in pancreatic cancer may pave the way to novel preventive and therapeutic approaches. Here we give an overview of the recruitment and differentiation of macrophages, TAM and pancreatic cancer progression and prognosis, as well as the potential preventive and therapeutic targets that interact with TAM for pancreatic cancer prevention and treatment.

KW - Chemoprevention

KW - Pancreatic cancer

KW - Tumor microenvironment

KW - Tumor-associated macrophages

UR - http://www.scopus.com/inward/record.url?scp=84981323605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981323605&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.9383

DO - 10.18632/oncotarget.9383

M3 - Article

VL - 7

SP - 50735

EP - 50754

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 31

ER -